- Home
- BSX vs WELL Comparison
BSX vs WELL Comparison
Compare BSX & WELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSX
- WELL
- Stock Information
- Founded
- BSX 1979
- WELL 1970
- Country
- BSX United States
- WELL United States
- Employees
- BSX N/A
- WELL N/A
- Industry
- BSX Medical/Dental Instruments
- WELL Real Estate Investment Trusts
- Sector
- BSX Health Care
- WELL Real Estate
- Exchange
- BSX Nasdaq
- WELL Nasdaq
- Market Cap
- BSX 146.2B
- WELL 117.8B
- IPO Year
- BSX 1992
- WELL N/A
- Fundamental
- Price
- BSX $99.78
- WELL $190.40
- Analyst Decision
- BSX Strong Buy
- WELL Strong Buy
- Analyst Count
- BSX 19
- WELL 10
- Target Price
- BSX $124.53
- WELL $192.00
- AVG Volume (30 Days)
- BSX 8.0M
- WELL 3.1M
- Earning Date
- BSX 10-22-2025
- WELL 10-27-2025
- Dividend Yield
- BSX N/A
- WELL 1.56%
- EPS Growth
- BSX 54.68
- WELL N/A
- EPS
- BSX 1.87
- WELL 1.46
- Revenue
- BSX $19,349,000,000.00
- WELL $9,907,853,000.00
- Revenue This Year
- BSX $21.04
- WELL $29.08
- Revenue Next Year
- BSX $11.45
- WELL $14.01
- P/E Ratio
- BSX $53.49
- WELL $130.39
- Revenue Growth
- BSX 21.61
- WELL 32.28
- 52 Week Low
- BSX $85.98
- WELL $123.11
- 52 Week High
- BSX $109.50
- WELL $190.68
- Technical
- Relative Strength Index (RSI)
- BSX 50.50
- WELL 72.68
- Support Level
- BSX $97.45
- WELL $174.91
- Resistance Level
- BSX $102.27
- WELL $189.53
- Average True Range (ATR)
- BSX 1.85
- WELL 4.60
- MACD
- BSX -0.11
- WELL 1.07
- Stochastic Oscillator
- BSX 28.98
- WELL 99.65
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
About WELL Welltower Inc.
Welltower owns a diversified healthcare portfolio of 2,391 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.